Parallel Processing

Shanley,Agnes;

Parallel Processing

May 15, 2017

By Agnes Shanley

Publication

Article

Pharmaceutical TechnologyPharmaceutical Technology-05-15-2017

Volume 2017 eBook

Issue 1

Pages: s8-s12

Samsung BioLogics’ aggressive growth strategy begs the question: Are there lessons that US and European pharma might still learn from the electronics industry?

A look at how engineering-led companies from outside pharma are transforming biopharmaceutical contract services, and an interview with Samsung BioLogics’ vice president and head of business development, James Park, on the company’s history, culture, and plans.

Download

Pharmaceutical Technology’s 2017 Biologics and Sterile Drug Manufacturing eBook

Articles in this issue

Clean, Disinfect, and Validate

Kill the Bioburden, Not the Biological Indicator

Cold Chain Logistics for Personalized Medicine: Dealing With Complexity

Ensuring the Biological Integrity of Raw Materials

Getting Biopharmaceutical Tech Transfer Right the First Time

Developing an Injectable Compound for a Dual- Chamber Delivery System

Case Study: Retrofitting Two New High-Purity Water Systems

Single-Use Bioreactors Have Reached the Big Time

Parallel Processing

Cost Considerations Drive Lean Technology in Biomanufacturing

Related Content

Gold winners award with three stars | Image Credit: © sergign - stock.adobe.com

ISPE Announces Six 2025 FOYA Category Winners

Patrick Lavery

May 15th 2025

Article

Six winners and two honorable mentions were revealed at ISPE’s Europe Annual Conference in London.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas

June 25th 2024

Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Piramal Pharma to Invest $90 Million at Kentucky & Michigan Sites

Patrick Lavery

May 12th 2025

Article

The company said the investment is in response not only to customer demand and a belief in the value of US-based innovation, but also because of the trend toward US onshoring brought about by new tariff policies.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol

April 30th 2024

Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Image Credit: © Alessandro Grandini - stock.adobe.com

Understanding the Variability in Bioburden Test Results in Biomanufacturing

Naveenganesh Muralidharan

May 7th 2025

Article

This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.